J9313
HCPCSInj., lumoxiti, 0.01 mg
Official HCPCS Level II long descriptor
Injection, moxetumomab pasudotox-tdfk, 0.01 mg
HCPCS Level II code J9313 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj., lumoxiti, 0.01 mg
Added to HCPCS: 2019-10-01
Nearby codes in J9
- J9304Inj. pemetrexed, 10 mg
- J9305Inj. pemetrexed nos 10mg
- J9306Injection, pertuzumab, 1 mg
- J9307Pralatrexate injection
- J9308Injection, ramucirumab
- J9309Inj, polatuzumab vedotin 1mg
- J9311Inj rituximab, hyaluronidase
- J9312Inj., rituximab, 10 mg
- J9314Inj pemetrexed (teva) 10mg
- J9316Pertuzu, trastuzu, 10 mg
- J9317Sacituzumab govitecan-hziy
- J9318Inj romidepsin non-lyo 0.1mg
- J9319Inj romidepsin lyophil 0.1mg
- J9320Streptozocin injection
- J9321Inj epcoritamab-bysp 0.16 mg
- J9322Inj pemetrexed (bluepoint)
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.